St. Louis, MO (PRWEB) May 18, 2013
Notal Vision has been named one of the 2013 winners of the Arch Grants Business Plan Competition. Out of 707 applicants from 15 countries and 40 states, Notal Vision will be one of 20 winners to receive $ 50,000 in funding and access to free support services.
The Arch Grant will help Notal Vision introduce their ForeseeHome AMD Monitoring Program nationwide. The ForeseeHome is the first FDA-cleared telemonitoring system for patients with age-related macular degeneration (AMD) and allows physicians to detect and treat the disease early.
We are honored to be one of the Arch Grant award winners, says U.S. General Manager, Garrett OConnell. As an Israeli company focused on growth in the U.S. market, we chose St. Louis for our U.S. headquarters. The central location and reasonable cost of living are just a couple of the benefits of St. Louis and were excited to be part of the growing community of medical and biotech start-ups here.